...
首页> 外文期刊>Modern Pathology >Extranodal Follicular Dendritic Cell Sarcoma of the Head and Neck Region: Three New Cases, with a Review of the Literature
【24h】

Extranodal Follicular Dendritic Cell Sarcoma of the Head and Neck Region: Three New Cases, with a Review of the Literature

机译:头颈部区域结外滤泡性树突状细胞肉瘤:三例新病例并文献复习

获取原文
           

摘要

Extranodal follicular dendritic cell (FDC) sarcoma of the head and neck region is uncommon, with 16 well-documented cases previously reported (four in the tonsil, four in the pharynx, two in the palate, five in the soft tissue, and one in the thyroid). We here report an additional three cases of extranodal FDC sarcoma in the tonsil (two cases) and pharynx (one case). In these new cases, the neoplastic cells were arranged in diffuse, fascicular, and vaguely whorled growth patterns. A background lymphocytic infiltrate was sprinkled throughout the neoplasms, with focal prominent perivascular cuffing. Scattered multinucleated giant cells were present. Immunohistochemically, tumor cells were strongly and diffusely positive for follicular dendritic cell markers CD21 and CD35. Tumor cells were diffusely positive for fascin and negative for leukocyte common antigen, S-100 protein, cytokeratin, and Epstein-Barr virus (EBV) latent membrane protein-1 (EBV-LMP). EBV was also not detected in the tumor cells by in situ hybridization for EBV-encoded RNAs. FDC sarcomas are probably an underrecognized neoplasm, especially when they occur in extranodal sites in the head and neck region. Two of the three new cases we report were initially misdiagnosed, and five cases of extranodal FDC sarcoma in the head and neck region reported in the recent literature were initially misdiagnosed. Our aim is to complement the current understanding of this neoplasm and alert pathologists to this rare entity in this region to avoid misdiagnosis. Recognition of extranodal FDC sarcoma requires a high index of suspicion, but this tumor has numerous distinctive histological features that should bring the neoplasm into the differential diagnosis. Confirmatory immunohistochemical staining with follicular dendritic cell markers such as CD21 and/or CD35 is essential for the diagnosis. Correct characterization of this neoplasm is imperative given its potential for recurrence and metastasis.
机译:头部和颈部的结外滤泡性树突状细胞(FDC)肉瘤很少见,以前有16例有据可查的病例报告(扁桃体4例,咽部4例,上two 2例,软组织5例,甲状腺)。我们在这里报告了另外3例扁桃体结节外FDC肉瘤(2例)和咽部(1例)。在这些新病例中,赘生性细胞排列成弥散,束状和模糊的轮生生长模式。整个肿瘤散布有背景淋巴细胞浸润,并伴有局灶性突出的血管周围套扎。存在分散的多核巨细胞。免疫组织化学观察,肿瘤细胞的滤泡树突状细胞标志物CD21和CD35呈强阳性和弥散阳性。肿瘤细胞的fascin弥漫阳性,而白细胞共同抗原,S-100蛋白,细胞角蛋白和Epstein-Barr病毒(EBV)潜伏膜蛋白1(EBV-LMP)呈阴性。通过原位杂交EBV编码的RNA,在肿瘤细胞中也未检测到EBV。 FDC肉瘤可能是未被充分认识的肿瘤,尤其是当它们发生在头颈部区域的结外部位时。我们报告的三例新病例中有两例最初被误诊,而最近文献中报道的头颈部区域结外FDC肉瘤中有五例最初被误诊。我们的目的是补充对这种肿瘤的当前理解,并提醒病理学家注意该区域的这种罕见实体,以避免误诊。识别结外FDC肉瘤需要高度怀疑,但这种肿瘤具有许多独特的组织学特征,应将肿瘤带入鉴别诊断。滤泡树突状细胞标记物(例如CD21和/或CD35)的确证性免疫组织化学染色对于诊断至关重要。考虑到其复发和转移的潜力,必须正确表征该肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号